1. Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria. Issue 4 (8th March 2017) Authors: Smolen, Josef S.; Aletaha, Daniel; Gruben, David; Zwillich, Samuel H.; Krishnaswami, Sriram; Mebus, Charles Journal: Arthritis & rheumatology Issue: Volume 69:Issue 4(2017) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study. Issue 2 (10th October 2022) Authors: Haraoui, Boulos; Khraishi, Majed; Choquette, Denis; Lisnevskaia, Larissa; Teo, Michelle; Kinch, Cassandra; Galos, Corina; Roy, Patrice; Gruben, David; Woolcott, John C.; Vaillancourt, Julie; Sampalis, John S.; Keystone, Edward C. Other Names: Pont Karen investigator.; Teo Michelle investigator.; Chan John investigator.; Jamal Shahin investigator.; Baker Milton investigator.; McCarthy Timothy investigator.; Khraishi Majed investigator.; Rahman Al‐Amin Proton investigator.; Sutton Evelyn investigator.; Lazovskis Juris investigator.; Pav... Journal: Arthritis care & research Issue: Volume 75:Issue 2(2023) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. Issue 1 (December 2015) Authors: Strand, Vibeke; Kremer, Joel; Wallenstein, Gene; Kanik, Keith; Connell, Carol; Gruben, David; Zwillich, Samuel; Fleischmann, Roy Journal: Arthritis research & therapy Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies. (25th July 2016) Authors: Fleischmann, Roy; Kremer, Joel; Tanaka, Yoshiya; Gruben, David; Kanik, Keith; Koncz, Tamas; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie; Zwillich, Samuel H.; Keystone, Edward Journal: International journal of rheumatic diseases Issue: Volume 19:Number 12(2016) Page Start: 1216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years. (13th August 2019) Authors: Pope, Janet; Bessette, Louis; Jones, Niall; Fallon, Lara; Woolcott, John; Gruben, David; Crooks, Michael; Gold, David; Haraoui, Boulos Journal: Rheumatology Issue: Volume 59:Number 3(2020) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials. Issue 1 (December 2016) Authors: Landewé, Robert; Connell, Carol; Bradley, John; Wilkinson, Bethanie; Gruben, David; Strengholt, Sander; van der Heijde, Désirée Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States. (2nd November 2018) Authors: Claxton, Lindsay; Taylor, Matthew; Gerber, Robert A.; Gruben, David; Moynagh, Dermot; Singh, Amitabh; Wallenstein, Gene V. Journal: Current medical research and opinion Issue: Volume 34:Number 11(2018) Page Start: 1991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P068 EXTRAINTESTINAL MANIFESTATIONS AND THEIR IMPACT ON REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ULCERATIVE COLITIS. (7th February 2019) Authors: Chapman, J C; DiBonaventura, Marco D; Comerford, Erin; Louder, Anthony; Smith, Tim; Lawendy, Nervin; Maller, Eric; Kayhan, Cem; Gruben, David; Soonasra, Arif Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. Issue 2 (1st October 2019) Authors: Strand, Vibeke; Mysler, Eduardo; Moots, Robert J; Wallenstein, Gene V; DeMasi, Ryan; Gruben, David; Soma, Koshika; Iikuni, Noriko; Smolen, Josef S; Fleischmann, Roy Journal: RMD open Issue: Volume 5:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States. Issue 6 (12th May 2020) Authors: Long, Millie D; Smith, Timothy W; Dibonaventura, Marco; Gruben, David; Bargo, Danielle; Salese, Leonardo; Quirk, Daniel Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗